Skip to main content

Table 4 Standardised difference of confounding variables between TPV/PR and BOC/PR patients after the three approaches to matching

From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

  After naïve matching After 0.1 caliper limit After 0.2 caliper limit
Treatment experinced 0.000 0.04 0.04
Presence of cirrhosis 0.000 0.022 0.022
Age −0.014 0.011 0.016
BMI −0.003 −0.005 −0.002
Baseline HCV > 800,000 0.019 0.019 0.019
GT1 −0.022 0.000 0.000
GT1b 0.019 0.039 0.039
IL28B CT 0.018 −0.018 −0.018
IL28B TT 0.027 0.072 0.028